Field-practice study of sorafenib therapy for hepatocellular carcinoma: a prospective multicenter study in Italy

Autor: Iavarone, M, Piscaglia, F, Zavaglia, C, Grieco, A, Villa, E, Colombo, M, Sangiovanni, A, Vavassori, S, Romeo, R, Borghi, A, Granito, A, Bolondi, L, Airoldi, A, Pinzello, G, Biolato, M, Racco, S, Pompili, M, Lei, B, De Maria, N., CABIBBO, Giuseppe, CAMMA', Calogero, DI MARCO, Vito, CRAXI, Antonio

A multicenter randomized controlled trial established sorafenib as a standard of care for patients with advanced hepatocellular carcinoma (HCC). Because the study was prematurely interrupted due to survival benefits in the sorafenib arm, we conducted

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87fecb35ca0cefad5cbb76cf3c33225a
http://hdl.handle.net/10807/33919

Evolving clinical landscape of chronic hepatitis B: A multicenter Italian study

Autor: Stroffolini T., Almasio P. L., Sagnelli E., Mele A., Gaeta G. B., Italian Hospitals' Collaborating Group, Scuteri A., Antonucci G., Iacomi F., Babudieri S., Pintus A., Stornaiuolo G., Brancaccio G., Brunetto M., Sasso R., Caporaso N., Morisco F., Chiaramonte M., Lattanzi E., Di Marco V., Venezia G., Fagiuoli S., Boninsegna S., Fattovich G., Olivari N., Ferrari C., Giuberti T., Ferrigno L., Magnani G., Massari M., Mangano C., Caserta C., Messina V., Pastore G., Palattella S., Piccinino F., Stanzione M., Pinzello G., Vinci M., Raimondo G., Caccamo G., Roffi L., Bellia V., Rizzetto M., Smedile A., Ciancio A., ANDREONE, PIETRO

Publikováno v: Journal of Medical Virology
Journal of Medical Virology, Wiley-Blackwell, 2009, 81 (12), pp.1999. ⟨10.1002/jmv.21643⟩

The aim of the study was to evaluate the characteristics of chronic hepatitis B with special reference to the geographical origin of the patients and to the prevalence of HBeAg and viral and non-viral co-factors of liver disease. A cross-sectional mu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbb32fbafae69845565809cf83a5b59a
http://hdl.handle.net/11570/3091929

Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia

Autor: Afdhal NH, Giannini EG, Tayyab G, Mohsin A, Lee JW, Andriulli A, Jeffers L, McHutchison J, Chen PJ, Han KH, Campbell F, Hyde D, Brainsky A, Theodore D, ELEVATE Study Group […, Akram J, Bessonova E, Bilodeau M, Bloomer J, Botta Fridlund D, Bzowej N, Calmus Y, Carbonell N, Caro Patón A, Cholewinska G, Chuang WL, Colombato L, Colombo M, Craxi A, Di Leo A, Diago M, Dumortier J, Elkasahab M, Everson G, Fallon M, Fedeli G, Finazzi R, Fontanella A, Francavilla A, Gadano A, Gambarin Gelwan M, Gordon F, Graus Morales J, Grieco A, Gugenheim J, Homenda W, Iaquinto G, Kang H, Khan Z, Kuliczkowski K, Kwo P, Lee JH, Lee W, Lee YS, Mazur W, Moreno C, Morozov V, Muñoz A, Navasa Anadón M, Nijhawan S, Pinzello G, Poordad F, Prieto Castillo M, Rafalsky V, Rapaccini G, Regenstein F, Rewak W, Riley T, Ripoll Noiseux C, Rizzetto M, Rodrigo Lopez J, Russo M, Samuel D, Sánchez Antolín G, Satyanaryana R, Savarino V, Shiffman M, Sigal S, Solá Lamoglia R, Sterling R, Tanno H, Te H, Terg R, Thuluvath P, Trepo C, Vargas H, Xiol Quingles X, Zaman A, Fontana R, Kim K, Abrams C, Gish R, Cardenas A, ANDREONE, PIETRO, MAZZELLA, GIUSEPPE

Eltrombopag is an oral thrombopoietin-receptor agonist. This study evaluated the efficacy of eltrombopag for increasing platelet counts and reducing the need for platelet transfusions in patients with thrombocytopenia and chronic liver disease who ar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94c4867da64475128d50da54cdaee7f6
http://hdl.handle.net/10807/33915

GENOTYPE 2 AND 3 RECCURENT HEPATITIS C AFTER LIVER TRANSPLANTATION: EXCELLENT RESULTS WITH SUBOPTIMAL DOSES OF ANTIVIRAL THERAPY

Autor: Vigano R, Ponziani FR, Belli LS, Vangeli M, Pinzello G, Gasbarrini A, Pasulo L, De Martin E, Burra P, Pompili M, Colledan M, Cillo U, Fagiuoli S

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::9e4dc83e97ee044f6b2cc230ff5d6af4
http://hdl.handle.net/10281/366332

GENOTYPE 2 AND 3 RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION: EXCELLENT RESULTS WITH SUBOPTIMAL DOSES OF ANTIVIRAL THERAPY

Autor: Ponziani FR, Vigano R, Belli L, Pinzello G, Colledan M, De Martin E, Burra P, Boninsegna S, Donato F, Di Paolo D, Angelico M, Rendina M, Pompili M, Gasbarrini A, Fagiuoli S

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1299::878cc30b454237dd2bc79681434fcec4
http://hdl.handle.net/10281/366242